RT @omarsiddiqi: Our review article on genetic testing in ATTR cardiac amyloidosis from @BU_Amyloidosis, led by first author Dr @dmgopalMO…
RT @BUcards: What impact does Genetic screening have on early identification of TTR mutation carriers? @dmgopalMO @omarsiddiqi & Dr. Rub…
What impact does Genetic screening have on early identification of TTR mutation carriers? @dmgopalMO @omarsiddiqi & Dr. Ruberg tell us all in their excellent review https://t.co/vWZOmWHKAy #cardiotwittter @The_BMC @BMCimRES @BUMedicine
RT @vsanchorawala: Congratulations on this great review @omarsiddiqi @dmgopalMO https://t.co/0qEfFpn0oO
Congratulations on this great review @omarsiddiqi @dmgopalMO
RT @BU_Amyloidosis: Congratulations to Dr. Deepa Gopal @dmgopalmo and Dr. Omar Siddiqi @omarsiddiqi for the review article on the impact of…
Congratulations to Dr. Deepa Gopal @dmgopalmo and Dr. Omar Siddiqi @omarsiddiqi for the review article on the impact of genetic testing in ATTR cardiac amyloidosis. Very timely with approved TTR silencers and stabilizers. https://t.co/iSkAO3lgGR
Our review article on genetic testing in ATTR cardiac amyloidosis from @BU_Amyloidosis, led by first author Dr @dmgopalMO : https://t.co/d3uRvpkVFb
Hereditary #amyloidosis review from @BU_Amyloidosis : "Practice guidelines are urgently needed to guide the clinical approach and to ensure that adequate genetic considerations are entertained when treating patient with ATTRv and their family members." htt
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. https://t.co/CGuMnLTem7